Skip to main content
. 2018 Nov 20;16:320. doi: 10.1186/s12967-018-1689-y

Table 3.

Associations between PD-L1, pSTAT3 and other clinicopathologic factors in diffuse large B cell lymphoma (n = 107)

PD-L1i PD-L1 translocation (A) PD-L1 gain/amplification (B) PD-L1 gene alteration (A + B) PD-L1 non-genetic expressionb pSTAT3a (continuous) pSTAT3 (> 40%)
PD-L1t R = 0.325
p = 0.001
R = 0.477
p < 0.001
R = 0.386
p < 0.001
R = 0.629
p < 0.001
R = 0.698
p < 0.001
R = 0.079
p = 0.429
R = 0.071
p = 0.466
PD-L1i R = 0.239
p = 0.015
R = 0.159
p = 0.109
R = 0.291
p = 0.003
R = 0.166
p = 0.092
R = 0.081
p = 0.414
R = 0.015
p = 0.879
PD-L1 translocation (A) R = − 0.051
p = 0.614
R = 0.758
p < 0.001
R = − 0.090
p = 0.364
R = − 0.049
p = 0.628
R = − 0.037
p = 0.714
PD-L1 gain/amplification (B) R = 0.613
p < 0.001
R = − 0.073
p = 0.464
R = − 0.117
p = 0.242
R = − 0.072
p = 0.470
PD-L1 gene alteration (A + B) R = − 0.120
p = 0.228
R = − 0.117
p = 0.245
R = − 0.021
p = 0.835
PD-L1 non-genetic expressionb R = 0.205
p = 0.033
R = 0.120
p = 0.224

Correlation coefficients (R) and p values by Pearson’s correlation

a Indicates the proportion (%) of tumor cells expressing pSTAT3 by using digital image analyzer

b Indicates PD-L1t+ cases with no alteration (translocation or gain/amplification) of PD-L1 gene